A New Practical Purification Method for Type D Clostridium perfringens Epsilon Toxin by Size-Exclusion Chromatography (SEC) and Ultrafiltration (UF)

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 212

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJVM-16-2_009

تاریخ نمایه سازی: 18 اسفند 1400

Abstract:

  BACKGROUND: The high potential toxicity of epsilon toxin (Etx) produced by Clostridium perfringens (C. perfringens) type D, has made it the third most lethal clostridial toxin behind botulinum and tetanus, therefore, having a pure and concentrated Etx is very important. OBJECTIVES: The aim of this study was to purify Etx as pure as possible with an applicable, cost-effective, multistep purification protocol with the lowest and shortest time. METHODS: The purification of the Etx was carried out in multiple consecutive steps; ammonium sulfate precipi-tation, dialysis, size exclusion chromatography by G۵۰, two concentration steps, and ultrafiltration. The Etx activity after different steps was evaluated by the minimum lethal dose (MLD) calculation, according to the standard oper-ating procedure. Toxin quantification was determined using Lowry technique, and its presence and specificity was tracked to identify pure Etx by SDS- PAGE and western blotting. Finally, the purity of Etx was evaluated by capil-lary electrophoresis. RESULTS: The purified Etx formed a single band of about ۳۲.۹ kDa in SDS-PAGE and blotting. The pure Etx concentration was calculated to be ۳.۹ mg/ml and its MLD value was the dilution of ۱/۲۴۰۰۰ after the ultrafiltration step. The presented purification processes to purify Etx resulted in ~ ۸۷-fold concentration and ۸۸.۶% purity. CONCLUSIONS: Due to this high Etx purity, the processes used in this study can provide the technical knowledge of toxin production in a larger industrial scale that can be used in development of clostridial toxoid vaccines, as well as quality control and/or diagnostic tests.

Authors

Molarameh Poudineh Morref

Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

Mohammad Kazem Koohi

Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

Mojtaba Alimolaei

Department of Research and Technology, Kerman branch, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Kerman, Iran

Tara Emami

Department of Proteomics and Biochemistry, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

Jalal Hassan

Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • ReferencesAlves, G. G., de Ávila, R. A. M., Chávez-Olórtegui, C. ...
  • Noman, A. S. M., Hoque, M. A., Sen, P. K., ...
  • Worthington, R. W., Mülders, M. S., & Van Rensburg, J. ...
  • نمایش کامل مراجع